Browse by Section 100 Item List

HIGHLY SPECIALISED DRUGS PROGRAM (Public Hospital)

For Highly Specialised Drugs prescribed through public hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Maximum quantities and repeats for Highly Specialised Drugs are listed in the Schedule. Highly Specialised Drugs prescribed through public hospitals, except Complex Authority Required Highly Specialised Drugs, are Authority required (STREAMLINED) PBS Prescriptions. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats. Complex Authority Required Highly Specialised Drugs require written authority applications. Approval of authority prescriptions by Services Australia may be obtained either by posting an Authority Prescription Form to Services Australia, or by using the Services Australia Authority free-call service (1800 888 333). Prescribers must quote the provider number of the hospital when applying.

Public hospital prescriptions for Highly Specialised Drugs can be dispensed by public hospital pharmacies. A patient will be required to pay a contribution for each supply of a highly specialised drug at a similar rate to the Pharmaceutical Benefits Scheme. Commonwealth subsidy is not available for hospital in-patients.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
  • SO
    Products that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.
    Supply Only
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 10183Y ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 1 1 5
MP 10190H ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 1 1 4
MP 10191J ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 1 1 0
MP 10525Y ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 1 1 6
MPNP 10978T ELBASVIR + GRAZOPREVIRelbasvir 50 mg + grazoprevir 100 mg tablet, 28 1 28 2
MPNP 10986F ELBASVIR + GRAZOPREVIRelbasvir 50 mg + grazoprevir 100 mg tablet, 28 1 28 3
MP 5825N ELTROMBOPAGeltrombopag 25 mg tablet, 28 1 28 5
MP 5826P ELTROMBOPAGeltrombopag 50 mg tablet, 28 1 28 5
MP 5720C EPOETIN ALFAepoetin alfa 3000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 5714R EPOETIN ALFAepoetin alfa 1000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MP 5716W EPOETIN ALFAepoetin alfa 6000 units/0.6 mL injection, 6 x 0.6 mL syringes 2 12 5
MP 5719B EPOETIN ALFAepoetin alfa 2000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MP 5722E EPOETIN ALFAepoetin alfa 10 000 units/mL injection, 6 x 1 mL syringes 2 12 5
MP 5721D EPOETIN ALFAepoetin alfa 4000 units/0.4 mL injection, 6 x 0.4 mL syringes 2 12 5
MP 5715T EPOETIN ALFAepoetin alfa 5000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MP 5717X EPOETIN ALFAepoetin alfa 8000 units/0.8 mL injection, 6 x 0.8 mL syringes 2 12 5
MP 5718Y EPOETIN ALFAepoetin alfa 40 000 units/mL injection, 1 mL syringe 2 2 5
MP 5713Q EPOETIN ALFAepoetin alfa 20 000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MP 5729M EPOETIN BETAepoetin beta 10 000 units/0.6 mL injection, 6 x 0.6 mL syringes 2 12 5
MP 5725H EPOETIN BETAepoetin beta 3000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 5724G EPOETIN BETAepoetin beta 2000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 5727K EPOETIN BETAepoetin beta 5000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 5728L EPOETIN BETAepoetin beta 6000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 5726J EPOETIN BETAepoetin beta 4000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 9669X EPOETIN LAMBDAepoetin lambda 2000 units/mL injection, 6 x 1 mL syringes 2 12 5
MP 9594Y EPOETIN LAMBDAepoetin lambda 8000 units/0.8 mL injection, 6 x 0.8 mL syringes 2 12 5
MP 9668W EPOETIN LAMBDAepoetin lambda 1000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MP 9587N EPOETIN LAMBDAepoetin lambda 4000 units/0.4 mL injection, 6 x 0.4 mL syringes 2 12 5
MP 9670Y EPOETIN LAMBDAepoetin lambda 3000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 9589Q EPOETIN LAMBDAepoetin lambda 5000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MP 9591T EPOETIN LAMBDAepoetin lambda 6000 units/0.6 mL injection, 6 x 0.6 mL syringes 2 12 5
MP 9596C EPOETIN LAMBDAepoetin lambda 10 000 units/mL injection, 6 x 1 mL syringes 2 12 5
MP 10130E EPOPROSTENOLepoprostenol 500 microgram injection, 1 vial 30 30 5
MP 10117L EPOPROSTENOLepoprostenol 1.5 mg injection, 1 vial 30 30 5
MP 11065J EPOPROSTENOLepoprostenol 1.5 mg injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack 30 30 5
MP 11090Q EPOPROSTENOLepoprostenol 500 microgram injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack 30 30 5
MP 5733R ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL syringes 1 1 0
MP 5735W ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL pen devices 1 1 0
MP 5734T ETANERCEPTetanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack 1 1 0
MP 5740D EVEROLIMUSeverolimus 750 microgram tablet, 60 4 240 5
MP 5737Y EVEROLIMUSeverolimus 1 mg tablet, 60 4 240 5
MP 5738B EVEROLIMUSeverolimus 250 microgram tablet, 60 2 120 5
MP 5739C EVEROLIMUSeverolimus 500 microgram tablet, 60 2 120 5